Evidence map›Paper›PMID 27924614›Full record

ArticleThe AAPS journal2017

GDF11 Treatment Attenuates the Recovery of Skeletal Muscle Function After Injury in Older Rats.

Yu Zhou, Neel Sharma, David Dukes, Maria B Myzithras, Priyanka Gupta, Ashraf Khalil, Julius Kahn, Jennifer S Ahlberg, David B Hayes, Michael Franti and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in The AAPS journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. GDF11 and aging biology - controversies resolved and pending.The journal of cardiovascular aging · 2023
    Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Sarcopenia and Muscle Aging: A Brief Overview.Endocrinology and metabolism (Seoul, Korea) · 2020
    Review
  9. Review
  10. Review
  11. Tissue engineering. Part C, Methods · 2017
    Article
  12. Article
  13. Review
  14. Article
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Yu ZhouWake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina, 27157, USA.
Neel SharmaWake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina, 27157, USA.
David DukesWake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina, 27157, USA.
Maria B MyzithrasBoehringer-Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA.
Priyanka GuptaBoehringer-Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA.
Ashraf KhalilBoehringer-Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA.
Julius KahnBoehringer-Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA.
Jennifer S AhlbergBoehringer-Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA.
David B HayesBoehringer-Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA.
Michael FrantiBoehringer-Ingelheim Pharmaceuticals, Ridgefield, Connecticut, USA.
Tracy CriswellWake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, North Carolina, 27157, USA. tcriswel@wakehealth.edu.
Boehringer Ingelheim (United States) · USForest Institute · USWake Forest University · US

Funding

Integrative Training in Trauma and Regenerative MedicineT32GM099606 · NIGMS · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI HOTH, JAMES JASON · 2013 to 2017
$1.0M
NIGMS NIH HHS T32 GM099606
6 · The paper itself

Abstract

Loss of skeletal muscle mass and function results in loss of mobility for elderly patients. Novel therapies that can protect and/or restore muscle function during aging would have profound effects on the quality of life for this population. Growth differentiation factor 11 (GDF11) has been proposed as a "youthful" circulating factor that can restore cardiac, neural, and skeletal muscle functions in aging animals. However, conflicting data has been recently published that casts doubt on these assertions. We used a complex rat model of skeletal muscle injury that physiologically mimics injuries seen in patients; to investigate the ability of GDF11 and to enhance skeletal muscle regeneration after injury in older rats. Our data showed that GDF11 treatment resulted in a significant increase in tissue fibrosis, accompanied by attenuated functional recovery, as compared to animals treated with vehicle alone. GDF11 impaired the recovery of skeletal muscle function in older rats after injury.

Indexed as

AgingAnimalsBone Morphogenetic ProteinsDisease Models, AnimalFibrosisGrowth Differentiation FactorsHumansMaleMuscle, SkeletalQuality of LifeRatsRats, Inbred LewRegenerationBone Morphogenetic ProteinsGDF11 protein, humanGrowth Differentiation FactorsGDF11regenerationsarcopeniaskeletal muscle

Identifiers

PMID27924614
OpenAlexW2560651231

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.